Abramson Cancer Center At Penn Medicine

We track 3 ClinicalTrials.gov studies led by Abramson Cancer Center At Penn Medicine. The portfolio skews toward Phase 2 (2 trials).

3 clinical trials sponsored by Abramson Cancer Center At Penn Medicine.

Pipeline by Phase

PhaseTrialsDistribution
Phase 2 2
67%
N/A 1
33%

Trial Status Breakdown

Trials by Abramson Cancer Center At Penn Medicine

QuantifyHER: Quantitative Immunofluorescence and/or RT-qPCR for Measuring HER2 in HER2-low Metastatic Breast Cancer

NCT06551116 · RECRUITING · N/A

Use of Natural Language Processing ChatBot and Automated Continuous Activity Monitoring Via Mobile Phones for Early Detection and Management of Symptoms in Patients Undergoing Cancer Treatment

NCT05318027 · ACTIVE NOT RECRUITING · Phase 2

A Phase II Trial of Avelumab or Hydroxychloroquine With or Without Palbociclib to Eliminate Dormant Breast Cancer (PALAVY)

NCT04841148 · RECRUITING · Phase 2

Frequently Asked Questions

How many clinical trials does Abramson Cancer Center At Penn Medicine sponsor?

Abramson Cancer Center At Penn Medicine currently sponsors 3 clinical trials tracked on ReadTheTrial. These span Phase 2, N/A.

What conditions does Abramson Cancer Center At Penn Medicine research?

Abramson Cancer Center At Penn Medicine conducts research across multiple therapeutic areas. Browse the trial listings for details.

Is Abramson Cancer Center At Penn Medicine recruiting for clinical trials?

Yes, Abramson Cancer Center At Penn Medicine currently has 2 trials that are actively recruiting participants. Check individual trial pages for eligibility criteria and locations.

Explore More